Variant report
Variant | nsv527104 |
---|---|
Chromosome Location | chr6:153775310-153801170 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:109931233..109932150-chr6:153783458..153784309,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199857393 | chr6:153781410-153781411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10485216 | chr6:153781434-153781435 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs143625405 | chr6:153781451-153781452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146779958 | chr6:153781463-153781464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535948865 | chr6:153781476-153781477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190550974 | chr6:153781542-153781543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572781858 | chr6:153781549-153781550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140522202 | chr6:153781587-153781588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546753784 | chr6:153781622-153781623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377382004 | chr6:153781639-153781640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546003940 | chr6:153781660-153781661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182993354 | chr6:153781678-153781679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13197698 | chr6:153781680-153781681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574957370 | chr6:153781710-153781711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541973422 | chr6:153781816-153781817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17084121 | chr6:153781862-153781863 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs150425883 | chr6:153781874-153781875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114579660 | chr6:153781916-153781917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145356485 | chr6:153781920-153781921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149179735 | chr6:153781976-153781977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182400937 | chr6:153782038-153782039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568340803 | chr6:153782042-153782043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555422320 | chr6:153782065-153782066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548006364 | chr6:153782075-153782076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575295843 | chr6:153782086-153782087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566457370 | chr6:153782135-153782136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533590778 | chr6:153782160-153782161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537804827 | chr6:153782179-153782180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558530875 | chr6:153782185-153782186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570712144 | chr6:153782195-153782196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77723448 | chr6:153782219-153782220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17308647 | chr6:153782247-153782248 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs574718755 | chr6:153782248-153782249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542288014 | chr6:153782265-153782266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187885162 | chr6:153782294-153782295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375311600 | chr6:153782326-153782327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs62436390 | chr6:153782352-153782353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62436391 | chr6:153782363-153782364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs68000580 | chr6:153782378-153782379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs564145415 | chr6:153782401-153782402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530625070 | chr6:153782459-153782460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139314510 | chr6:153782485-153782486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12526771 | chr6:153782560-153782561 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs561922053 | chr6:153782576-153782577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529506980 | chr6:153782587-153782588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs193048759 | chr6:153782613-153782614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557582091 | chr6:153782640-153782641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573865552 | chr6:153782643-153782644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566403066 | chr6:153782697-153782698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35589255 | chr6:153782727-153782728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:153781400-153783200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:153783200-153783800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:153783800-153784000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:153800200-153801000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:153801000-153804000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |